UniProt ID | CALX_MOUSE | |
---|---|---|
UniProt AC | P35564 | |
Protein Name | Calnexin | |
Gene Name | Canx | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 591 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type I membrane protein . Endoplasmic reticulum . Melanosome . The palmitoylated form preferentially localizes to the perinuclear rough ER (By similarity). When bound to CD3 epsilon chains, calnexin's ER r |
|
Protein Description | Calcium-binding protein that interacts with newly synthesized glycoproteins in the endoplasmic reticulum. It may act in assisting protein assembly and/or in the retention within the ER of unassembled protein subunits. It seems to play a major role in the quality control apparatus of the ER by the retention of incorrectly folded proteins. Associated with partial T-cell antigen receptor complexes that escape the ER of immature thymocytes, it may function as a signaling complex regulating thymocyte maturation. Additionally it may play a role in receptor-mediated endocytosis at the synapse.. | |
Protein Sequence | MEGKWLLCLLLVLGTAAVEAHDGHDDDAIDIEDDLDDVIEEVEDSKSKSDASTPPSPKVTYKAPVPTGEVYFADSFDRGSLSGWILSKAKKDDTDDEIAKYDGKWEVDEMKETKLPGDKGLVLMSRAKHHAISAKLNKPFLFDTKPLIVQYEVNFQNGIECGGAYVKLLSKTAELSLDQFHDKTPYTIMFGPDKCGEDYKLHFIFRHKNPKTGVYEEKHAKRPDADLKTYFTDKKTHLYTLILNPDNSFEILVDQSVVNSGNLLNDMTPPVNPSREIEDPEDRKPEDWDERPKIADPDAVKPDDWDEDAPSKIPDEEATKPEGWLDDEPEYIPDPDAEKPEDWDEDMDGEWEAPQIANPKCESAPGCGVWQRPMIDNPNYKGKWKPPMIDNPNYQGIWKPRKIPNPDFFEDLEPFKMTPFSAIGLELWSMTSDIFFDNFIISGDRRVVDDWANDGWGLKKAADGAAEPGVVLQMLEAAEERPWLWVVYILTVALPVFLVILFCCSGKKQSNAMEYKKTDAPQPDVKDEEGKEEEKNKRDEEEEEEKLEEKQKSDAEEDGVTGSQDEEDSKPKAEEDEILNRSPRNRKPRRE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Phosphorylation | EEVEDSKSKSDASTP HHHHHHCCCCCCCCC | 41.15 | 29899451 | |
48 | Acetylation | EVEDSKSKSDASTPP HHHHHCCCCCCCCCC | 56.97 | 23806337 | |
48 | Succinylation | EVEDSKSKSDASTPP HHHHHCCCCCCCCCC | 56.97 | 23806337 | |
49 | Phosphorylation | VEDSKSKSDASTPPS HHHHCCCCCCCCCCC | 45.56 | 30635358 | |
52 | Phosphorylation | SKSKSDASTPPSPKV HCCCCCCCCCCCCCE | 46.57 | 27742792 | |
53 | Phosphorylation | KSKSDASTPPSPKVT CCCCCCCCCCCCCEE | 40.72 | 27742792 | |
56 | Phosphorylation | SDASTPPSPKVTYKA CCCCCCCCCCEEEEC | 38.26 | 27742792 | |
67 | Phosphorylation | TYKAPVPTGEVYFAD EEECCCCCCEEEEEC | 46.32 | - | |
82 | Phosphorylation | SFDRGSLSGWILSKA CCCCCCCHHHHHHHH | 33.50 | 22817900 | |
104 | Acetylation | EIAKYDGKWEVDEMK HHHHHCCCEEHHHCH | 36.96 | 23954790 | |
104 | Succinylation | EIAKYDGKWEVDEMK HHHHHCCCEEHHHCH | 36.96 | 23954790 | |
133 | Phosphorylation | RAKHHAISAKLNKPF CCHHHHHHHCCCCCC | 21.82 | 18779572 | |
138 | Succinylation | AISAKLNKPFLFDTK HHHHCCCCCCCCCCC | 47.81 | 23954790 | |
138 | Acetylation | AISAKLNKPFLFDTK HHHHCCCCCCCCCCC | 47.81 | - | |
171 | Succinylation | AYVKLLSKTAELSLD HHHHHHHCCEECCHH | 52.29 | 23954790 | |
171 | Ubiquitination | AYVKLLSKTAELSLD HHHHHHHCCEECCHH | 52.29 | - | |
186 | Phosphorylation | QFHDKTPYTIMFGPD HHCCCCCEEEEECCC | 17.71 | 18779572 | |
187 | Phosphorylation | FHDKTPYTIMFGPDK HCCCCCEEEEECCCC | 13.73 | 18779572 | |
195 | S-palmitoylation | IMFGPDKCGEDYKLH EEECCCCCCCCEEEE | 10.59 | 26165157 | |
218 | Acetylation | KTGVYEEKHAKRPDA CCCCCCHHHCCCCCC | 36.60 | 21728379 | |
228 | Succinylation | KRPDADLKTYFTDKK CCCCCCHHHHCCCCC | 41.55 | 23954790 | |
459 | Acetylation | ANDGWGLKKAADGAA HHCCCCCHHHHCCCC | 36.11 | 129529 | |
459 | Succinylation | ANDGWGLKKAADGAA HHCCCCCHHHHCCCC | 36.11 | 23954790 | |
460 | Acetylation | NDGWGLKKAADGAAE HCCCCCHHHHCCCCC | 54.58 | 156285 | |
503 | S-palmitoylation | VFLVILFCCSGKKQS HHHHHHHHCCCCHHH | 1.29 | - | |
504 | S-palmitoylation | FLVILFCCSGKKQSN HHHHHHHCCCCHHHC | 4.75 | - | |
516 | Acetylation | QSNAMEYKKTDAPQP HHCCCHHCCCCCCCC | 35.57 | 6566661 | |
517 | Ubiquitination | SNAMEYKKTDAPQPD HCCCHHCCCCCCCCC | 51.22 | 22790023 | |
517 | Acetylation | SNAMEYKKTDAPQPD HCCCHHCCCCCCCCC | 51.22 | 6566727 | |
526 | Ubiquitination | DAPQPDVKDEEGKEE CCCCCCCCCCCCHHH | 67.79 | 22790023 | |
531 | Ubiquitination | DVKDEEGKEEEKNKR CCCCCCCHHHHHHHC | 66.29 | - | |
535 | Ubiquitination | EEGKEEEKNKRDEEE CCCHHHHHHHCHHHH | 71.67 | 22790023 | |
537 | Ubiquitination | GKEEEKNKRDEEEEE CHHHHHHHCHHHHHH | 72.75 | 22790023 | |
546 | Ubiquitination | DEEEEEEKLEEKQKS HHHHHHHHHHHHHHH | 65.56 | 22790023 | |
546 | Acetylation | DEEEEEEKLEEKQKS HHHHHHHHHHHHHHH | 65.56 | 23954790 | |
550 | Ubiquitination | EEEKLEEKQKSDAEE HHHHHHHHHHHHHHH | 54.36 | 22790023 | |
553 | Phosphorylation | KLEEKQKSDAEEDGV HHHHHHHHHHHHHCC | 39.29 | 24925903 | |
561 | Phosphorylation | DAEEDGVTGSQDEED HHHHHCCCCCCCCCC | 36.32 | 27087446 | |
563 | Phosphorylation | EEDGVTGSQDEEDSK HHHCCCCCCCCCCCC | 25.70 | 24925903 | |
569 | Phosphorylation | GSQDEEDSKPKAEED CCCCCCCCCCCHHHH | 54.88 | 24925903 | |
582 | Phosphorylation | EDEILNRSPRNRKPR HHHHHHCCCCCCCCC | 27.43 | 24925903 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
563 | S | Phosphorylation | Kinase | MAPK3 | Q63844 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
563 | S | Phosphorylation |
| 17208939 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CALX_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CALX_MOUSE | Canx | physical | 8798466 | |
ACHA_MOUSE | Chrna1 | physical | 8798466 | |
ACHB_MOUSE | Chrnb1 | physical | 8798466 | |
ACHD_MOUSE | Chrnd | physical | 8798466 | |
HA11_MOUSE | H2-D1 | physical | 9973410 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582, AND MASSSPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553 AND SER-582, ANDMASS SPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553; SER-563 ANDSER-582, AND MASS SPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582, AND MASSSPECTROMETRY. | |
"Mitochondrial phosphoproteome revealed by an improved IMAC method andMS/MS/MS."; Lee J., Xu Y., Chen Y., Sprung R., Kim S.C., Xie S., Zhao Y.; Mol. Cell. Proteomics 6:669-676(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553; SER-563; SER-569AND SER-582, AND MASS SPECTROMETRY. | |
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553; THR-561; SER-563AND SER-582, AND MASS SPECTROMETRY. | |
"A differential phosphoproteomic analysis of retinoic acid-treated P19cells."; Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.; J. Proteome Res. 6:3174-3186(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553; THR-561 ANDSER-563, AND MASS SPECTROMETRY. | |
"Proteomic analysis of in vivo phosphorylated synaptic proteins."; Collins M.O., Yu L., Coba M.P., Husi H., Campuzano I.,Blackstock W.P., Choudhary J.S., Grant S.G.; J. Biol. Chem. 280:5972-5982(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553 AND SER-563, ANDMASS SPECTROMETRY. | |
"Identification of phosphoproteins and their phosphorylation sites inthe WEHI-231 B lymphoma cell line."; Shu H., Chen S., Bi Q., Mumby M., Brekken D.L.; Mol. Cell. Proteomics 3:279-286(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582, AND MASSSPECTROMETRY. |